Delivery Order SPE2DB22D3011-SPE2DB25FQ2TY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18 count) with a ceiling value of $2,561.75. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by October 31, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $2,218.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by July 28, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mucinex D ER 600-60 mg tablets in quantities of 18 units. This firm fixed-price delivery order, valued at $10,118.97, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,167.50 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (36-count packages). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for ultimate completion on November 19, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packaging) with a ceiling value of $1,629.37. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, indicating it was competed among qualified suppliers in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) valued at $2,635.59. This firm fixed price delivery order, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. The contract will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units) with a ceiling value of $3,206.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mucinex D ER 1,200-120 mg tablets (24-count packages) valued at $3,066.65. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.78 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,219.54. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2TYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a contract value of $4,795.68. This non-competitive, firm fixed-price delivery order is set to conclude on September 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain, reflecting the company's role as a critical distributor of medications to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across varying transaction sizes and therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/16/25 |